Addition of Benfluorex to Biguanide Improves Glycemic Control in Obese Non–Insulin-Dependent Diabetes-Reference-Cited by-同舟云学术

Addition of Benfluorex to Biguanide Improves Glycemic Control in Obese Non–Insulin-Dependent Diabetes

Published:1999-03 Issue:2 Volume:13 Page:62-67
ISSN:1056-8727
Container-title:Journal of Diabetes and its Complications
language:en
Short-container-title:Journal of Diabetes and its Complications

Author:

Roger Patrick,Auclair Jean,Drain Patrice

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference19 articles.

1. Antiobesity and lipid-lowering agents with anit-diabetic activity,;Arnauld,1990

2. Insulinorésistance, diabète non insulinodépendant et approches thérapeutiques;Richard;Diabétologie,1996

3. Research prospects with benfluorex;Ravel;J Diabetes Complications,1996

4. Étude à long terme de l’efficacité du benfluorex (Mediator) chez 83 patients hyperlipidémiques (types II B et IV) présentant une glycémie normale, ou une anomalie de la tolérance au glucose, ou un diabète insulinodépendant;Bertolini;Sem Hôp Paris,1984

5. Intérêt de l’association du benfluorex à l’insuline ou aux sulfamides hypoglycémiants;Velussi;Vie Med,1986

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. It’s Time to Include Harm to Humans in Harm–Benefit Analysis — But How to Do It, That is the Question;Alternatives to Laboratory Animals;2021-09

2. Benfluorex;Meyler's Side Effects of Drugs;2016

3. Central nervous system stimulants and drugs that suppress appetite;A worldwide yearly survey of new data in adverse drug reactions and interactions;2012

4. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus;Cochrane Database of Systematic Reviews;2010-04-14

5. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus;Cochrane Database of Systematic Reviews;2010-01-20